Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Introduction and Objectives. Neutrophil-to-lymphocyte ratio (NLR) has been suggested to be a simple marker of the systemic inflammatory response in critical care patients. We previously assessed the utility of NLR as a biomarker to predict tumor recurrence and cancer death in bladder cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohtake, Shinji, Kawahara, Takashi, Kasahara, Ryo, Ito, Hiroki, Osaka, Kimito, Hattori, Yusuke, Teranishi, Jun-ichi, Makiyama, Kazuhide, Mizuno, Nobuhiko, Umemoto, Susumu, Miyoshi, Yasuhide, Nakaigawa, Noboru, Miyamoto, Hiroshi, Yao, Masahiro, Uemura, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086366/
https://www.ncbi.nlm.nih.gov/pubmed/27822480
http://dx.doi.org/10.1155/2016/9846823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086366/
https://www.ncbi.nlm.nih.gov/pubmed/27822480
http://dx.doi.org/10.1155/2016/9846823

Ejemplares similares